Susceptibilities to clarithromycin, amoxycillin and metronidazole of Helicobacter pylori isolates from the antrum and corpus in Tokyo, Japan, 1995–2001 

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Helicobacter pylori infection and gastric carcinoma
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Helicobacter pylori resistance to antibiotics in 2014 in France detected by phenotypic and genotypic methods  A. Ducournau, L. Bénéjat, E. Sifré, E. Bessède,
Susceptibilities to clarithromycin, amoxycillin and metronidazole of Helicobacter pylori isolates from the antrum and corpus in Tokyo, Japan, 1995–2001 
L. Boyanova  Clinical Microbiology and Infection 
Helicobacter pylori infection and gastric carcinoma
Gut bacterial microbiota and obesity
Approach to diagnosis of infective endocarditis
P. Clarke, S. Murchan, E.G. Smyth, H. Humphreys 
Migrant health—a cause for concern?
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
A.K. Reddy, P. Garg, I. Kaur  Clinical Microbiology and Infection 
In-vitro susceptibility and molecular characterisation of macrolide resistance mechanisms among Streptococcus pneumonia isolates in The Netherlands: the.
J.-P. Van geertruyden  Clinical Microbiology and Infection 
Gentamicin susceptibility in Escherichia coli related to the genetic background: problems with breakpoints  L. Jakobsen, D. Sandvang, V.F. Jensen, A.M.
Laboratory handling of Helicobacter pylori critically influences the results of in-vitro metronidazole resistance determination  T.H. Henriksen, F. Lerang,
The use of AP-PCR and flaA-RFLP typing to investigate treatment failure in Helicobacter pylori infection  I. Adamsson, C. Edlund, R. Seensalu, L. Engstrand 
R. Cantón  Clinical Microbiology and Infection 
Genital Chlamydia trachomatis infections
Louis Pasteur, from crystals of life to vaccination
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia  D. Kese, M. Maticic, M. Potocnik  Clinical.
Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice?  T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt 
Clinical Microbiology and Infection
W. Witte, B. Pasemann, C. Cuny  Clinical Microbiology and Infection 
Polycolonization of Helicobacter pylori among Chinese subjects
Vector control: a cornerstone in the malaria elimination campaign
L. T. Nguyen, T. Uchida, Y. Tsukamoto, A. Kuroda, T. Okimoto, M
The normal gastric microflora and Helicobacter pylori; before, during and after treatment with omeprazole and amoxycillin  Inger Adamsson, Charlotta Edlund,
L. Gatta, C. Ricci, A. Tampieri, D. Vaira 
Sofie Arens, Jan Verhaegen, Ludo Verbist 
Training for the infectious diseases speciality in Norway
B. Gordts  Clinical Microbiology and Infection 
A. Cosme, M. Montes, M. Martos, I. Gil, U. Mendarte, Y. Salicio, L
Elements of design: the knowledge on which we build
Microbiological and epidemiological studies of Enterococcus faecium resistant to amoxycillin in a university hospital in eastern France  M. Thouverez,
Levofloxacin in the treatment of ventilator-associated pneumonia
Metagenomics and probiotics
Effect of antioxidants on the immune response of Helicobacter pylori
Erythromycin susceptibility of viridans streptococci from the normal throat flora of patients treated with azithromycin or clarithromycin  King A. , Bathgate.
Laboratory diagnosis of Clostridium difficile disease
N. Maggi-Solcà, C. Valsangiacomo, J.-C. Piffaretti 
The practice of travel medicine in Europe
T.M. File  Clinical Microbiology and Infection 
Update on antifungal resistance in Aspergillus and Candida
Harmonised monitoring of antimicrobial resistance in Salmonella and Campylobacter isolates from food animals in the European Union  S. Bronzwaer  Clinical.
Abstracts cont. Clinical Microbiology and Infection
Pandemic lineages of extraintestinal pathogenic Escherichia coli
Effect of metronidazole versus standard care on length of stay of patients admitted with severe infectious mononucleosis: a randomized controlled trial 
Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida 
Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan  Y.-C. Hsieh, L.-Y. Chang, Y.-C. Huang, H.-C. Lin,
The use of AP-PCR and flaA-RFLP typing to investigate treatment failure in Helicobacter pylori infection  I. Adamsson, C. Edlund, R. Seensalu, L. Engstrand 
An after-hours clinical liaison blood culture service—is it worth it?
Statin use and clinical outcomes among pneumonia patients
Clinical Microbiology and Infection
Clinical Microbiology and Infection
Evaluation of the performance of the Helico Blot 2
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
The atypical pneumonias: clinical diagnosis and importance
Abstracts Clinical Microbiology and Infection
Modelling during an emergency: the 2009 H1N1 influenza pandemic
Antibiotic resistance of Helicobacter pylori: a cross-sectional study in consecutive patients, and relation to ethnicity  R.J.L.F. Loffeld, C.A.P.M.J.
Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group†   H. Goossens  Clinical.
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
Comparative study of pediculicidal effect of medical plants
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Presentation transcript:

Susceptibilities to clarithromycin, amoxycillin and metronidazole of Helicobacter pylori isolates from the antrum and corpus in Tokyo, Japan, 1995–2001  E. Rimbara, N. Noguchi, M. Tanabe, T. Kawai, Y. Matsumoto, M. Sasatsu  Clinical Microbiology and Infection  Volume 11, Issue 4, Pages 307-311 (April 2005) DOI: 10.1111/j.1469-0691.2005.01099.x Copyright © 2005 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Annual variation in MIC90s of (a) clarithromycin, (b) amoxycillin and (c) metronidazole for Helicobacter pylori isolates between 1995 and 2001. Squares, H. pylori isolates from the antrum; triangles, H. pylori isolates from the corpus. Clinical Microbiology and Infection 2005 11, 307-311DOI: (10.1111/j.1469-0691.2005.01099.x) Copyright © 2005 European Society of Clinical Infectious Diseases Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.